Renan Amphilophio Fernandes

Prof. Renan Amphilophio Fernandes

Federal University of the State of Rio de Janeiro, Rio de Janeiro, Brazil
orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 January 2016 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
DRDaniel Rodrigues
Daniel Rodrigues
GFGuilherme À. Ferreira-Silva
Guilherme À. Ferreira-Silva
AFAna C. S. Ferreira
Ana C. S. Ferreira
RFRenan Amphilophio Fernandes
Renan Amphilophio Fernandes
JKJolie K. Kwee
Jolie K. Kwee
Carlos FragaCarlos Fraga
Carlos Fraga

27 April 2024 in Molecular Psychiatry
Verified
Journal Article
Open access
PDF file
EGElisa Gouvea Gutman
Elisa Gouvea Gutman
ASAndreza Salvio Lemos Salvio
Andreza Salvio Lemos Salvio
RFRenan Amphilophio Fernandes
Renan Amphilophio Fernandes
LDLarissa Araujo Duarte
Larissa Araujo Duarte
JRJessica Vasques Raposo-Vedovi
Jessica Vasques Raposo-Vedovi
SASoniza Vieira Alves-Leon
Soniza Vieira Alves-Leon
It is well known the potential of severe acute respiratory coronavirus type 2 (SARS-CoV-2) infection to induce post-acute sequelae, a condition called Long COVID. This syndrome includes several symptoms, but the central nervous system (CNS) main one is neurocognitive dysfunction. Recently it has been demonstrated the relevance of plasma levels of neurofilament light chain (pNfL), as a biomarker of early involvement of the CNS in COVID-19. The aim of this study was to investigate the relationship between pNfL in patients with post-acute neurocognitive symptoms and the potential of NfL as a prognostic biomarker in these cases. A group of 63 long COVID patients ranging from 18 to 59 years-old were evaluated, submitted to a neurocognitive battery assessment, and subdivided in different groups, according to results. Plasma samples were collected during the long COVID assessment and used for measurement of pNfL with the Single molecule array (SIMOA) assays. Levels of pNfL were significantly higher in long COVID patients with neurocognitive symptoms when compared to HC (p = 0.0031). Long COVID patients with cognitive impairment and fatigue symptoms presented higher pNfL levels when compared to long COVID patients without these symptoms, individually and combined (p = 0.0263, p = 0.0480, and 0.0142, respectively). Correlation analysis showed that levels of cognitive lost and exacerbation of fatigue in the neurocognitive evaluation had a significative correlation with higher pNfL levels (p = 0.0219 and 0.0255, respectively). Previous reports suggested that pNfL levels are related with higher risk of severity and predict lethality of COVID-19. Our findings demonstrate that SARS-CoV-2 infection seems to have a long-term impact on the brain, even in patients who presented mild acute disease. NfL measurements might be useful to identify CNS involvement in long COVID associated with neurocognitive symptoms and to identify who will need continuous monitoring and treatment support.

1 December 2023 in Microorganisms
Verified
Journal Article
Open access
PDF file
EGElisa Gouvea Gutman
Elisa Gouvea Gutman
RFRenan Amphilophio Fernandes
Renan Amphilophio Fernandes
JRJéssica Vasques Raposo-Vedovi
Jéssica Vasques Raposo-Vedovi
ASAndreza Salvio Lemos Salvio
Andreza Salvio Lemos Salvio
LDLarissa Araujo Duarte
Larissa Araujo Duarte
SASoniza Vieira Alves-Leon
Soniza Vieira Alves-Leon
SARS-CoV-2 can trigger autoimmune central nervous system (CNS) diseases in genetically susceptible individuals, a mechanism poorly understood. Molecular mimicry (MM) has been identified in other viral diseases as potential triggers of autoimmune CNS events. This study investigated if MM is the process through which SARS-CoV-2 induces the breakdown of immune tolerance. The frequency of autoimmune CNS disorders was evaluated in a prospective cohort with patients admitted to the COVID-19 Intense Care Unity (ICU) in Rio de Janeiro. Then, an in silico analysis was performed to identify the conserved regions that share a high identity between SARS-CoV-2 antigens and human proteins. The sequences with significant identity and antigenic properties were then assessed for their binding capacity to HLA subtypes. Of the 112 patients included, 3 were classified as having an autoimmune disorder. A total of eleven combinations had significant linear and three-dimensional overlap. NMDAR1, MOG, and MPO were the self-antigens with more significant combinations, followed by GAD65. All sequences presented at least one epitope with strong or intermediate binding capacity to the HLA subtypes selected. This study underscores the possibility that CNS autoimmune attacks observed in COVID-19 patients, including those in our population, could be driven by MM in genetically predisposed individuals.

1 December 2011 in Journal of Cancer Research and Clinical Oncology
Verified
Journal Article
Closed access
PDF file
AFAna Carolina dos Santos Ferreira
Ana Carolina dos Santos Ferreira
RFRenan Amphilophio Fernandes
Renan Amphilophio Fernandes
JKJolie Kiemlian Kwee
Jolie Kiemlian Kwee
CKClaudete Klumb
Claudete Klumb

Verified
Journal Article
Open access
PDF file
LCLiliane Tavares de Faria Cavalcante
Liliane Tavares de Faria Cavalcante
GFGuilherme Cordenonsi da Fonseca
Guilherme Cordenonsi da Fonseca
LLLuciane Amado Leon
Luciane Amado Leon
ASAndreza Salvio Lemos Salvio
Andreza Salvio Lemos Salvio
OBOTAVIO JOSE BERNARDES BRUSTOLINI
OTAVIO JOSE BERNARDES BRUSTOLINI
AVAna Tereza Ribeiro de Vasconcelos
Ana Tereza Ribeiro de Vasconcelos
Transcriptome studies have reported the dysregulation of cell cycle-related genes and the global inhibition of host mRNA translation in COVID-19 cases. However, the key genes and cellular mechanisms that are most affected by the severe outcome of this disease remain unclear. For this work, the RNA-seq approach was used to study the differential expression in buffy coat cells of two groups of people infected with SARS-CoV-2: (a) Mild, with mild symptoms; and (b) SARS (Severe Acute Respiratory Syndrome), who were admitted to the intensive care unit with the severe COVID-19 outcome. Transcriptomic analysis revealed 1009 up-regulated and 501 down-regulated genes in the SARS group, with 10% of both being composed of long non-coding RNA. Ribosome and cell cycle pathways were enriched among down-regulated genes. The most connected proteins among the differentially expressed genes involved transport dysregulation, proteasome degradation, interferon response, cytokinesis failure, and host translation inhibition. Furthermore, interactome analysis showed Fibrillarin to be one of the key genes affected by SARS-CoV-2. This protein interacts directly with the N protein and long non-coding RNAs affecting transcription, translation, and ribosomal processes. This work reveals a group of dysregulated processes, including translation and cell cycle, as key pathways altered in severe COVID-19 outcomes.

1 September 2013 in Experimental Parasitology
Verified
Journal Article
Closed access
RSRomulo J. Soares-Bezerra
Romulo J. Soares-Bezerra
LLLeonor Laura Leon
Leonor Laura Leon
AEAurea Echevarria
Aurea Echevarria
CRCamilla M. Reis
Camilla M. Reis
LGLiliane Gomes-Silva
Liliane Gomes-Silva
MGMarcelo S. Genestra
Marcelo S. Genestra